feed,title,long_url,short_url
BioRxiv,Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro,https://biorxiv.org/cgi/content/short/2020.11.25.398859v1?rss=1,https://j.mp/2HDDn4e
BioRxiv,Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods,https://biorxiv.org/cgi/content/short/2020.11.26.399436v1?rss=1,https://j.mp/366GeMx
BioRxiv,"Triple Combination Nitazoxanide, Ribavirin, and Hydroxychloroquine results in the multiplicative reduction of in vitro SARS-CoV-2 viral replication",https://biorxiv.org/cgi/content/short/2020.11.25.399055v1?rss=1,https://j.mp/39kRsPI
